Emmanuel Favaloro
Emmanuel Favaloro
ICPMR, Sydney Centres for Thrombosis & Haemostasis, Westmead Hospital, NSW Health Pathology.
health.nsw.gov.au üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ...
Journal of the American college of cardiology 75 (23), 2950-2973, 2020
14822020
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor
JE Sadler, U Budde, JCJ Eikenboom, EJ Favaloro, FGH Hill, L Holmberg, ...
Journal of thrombosis and haemostasis 4 (10), 2103-2114, 2006
11032006
Characterization of GMP-140 (P-selectin) as a circulating plasma protein.
LC Dunlop, MP Skinner, LJ Bendall, EJ Favaloro, PA Castaldi, JJ Gorman, ...
The Journal of experimental medicine 175 (4), 1147-1150, 1992
4321992
D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis
G Lippi, EJ Favaloro
Thrombosis and haemostasis 120 (5), 876, 2020
3082020
Clinical utility of the PFA-100
EJ Favaloro
Seminars in thrombosis and hemostasis 34 (08), 709-733, 2008
2992008
Influence of posture on routine hemostasis testing
G Lippi, GL Salvagno, G Lima-Oliveira, E Danese, EJ Favaloro, GC Guidi
Blood Coagulation & Fibrinolysis 26 (6), 716-719, 2015
2852015
The paradoxical relationship between serum uric acid and cardiovascular disease
G Lippi, M Montagnana, M Franchini, EJ Favaloro, G Targher
Clinica Chimica Acta 392 (1-2), 1-7, 2008
2682008
Moderate red wine consumption and cardiovascular disease risk: beyond the “French paradox”
G Lippi, M Franchini, EJ Favaloro, G Targher
Seminars in thrombosis and hemostasis 31 (01), 059-070, 2010
2312010
Clinical application of the PFA-100®
EJ Favaloro
Current opinion in hematology 9 (5), 407-415, 2002
2112002
International Consensus Guidelines on Anticardiolipin and Anti–2-Glycoprotein I Testing
G Lakos, EJ Favaloro, EN Harris, PL Meroni, A Tincani, RC Wong, ...
Arthritis & Rheumatism 64 (1), 1-10, 2012
1962012
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management …
U Budde, R Schneppenheim, J Eikenboom, A Goodeve, K Will, E Drewke, ...
Journal of thrombosis and haemostasis 6 (5), 762-771, 2008
1872008
Quality standards for sample collection in coagulation testing
G Lippi, GL Salvagno, M Montagnana, G Lima-Oliveira, GC Guidi, ...
Seminars in thrombosis and hemostasis 38 (06), 565-575, 2012
1862012
Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis
EJ Favaloro, G Lippi, DM Adcock
Semin Thromb Hemost 34 (7), 612-634, 2008
1862008
Collagen binding assay for von Willebrand factor (VWF: CBA): detection of von Willebrands Disease (VWD), and discrimination of VWD subtypes, depends on collagen source
EJ Favaloro
Thrombosis and haemostasis 83 (01), 127-135, 2000
1862000
Obstructive sleep apnea syndrome and cardiovascular diseases
C Fava, M Montagnana, EJ Favaloro, GC Guidi, G Lippi
Seminars in thrombosis and hemostasis 37 (03), 280-297, 2011
1732011
Template bleeding time and PFA‐100® have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients
T Quiroga, M Goycoolea, B Munoz, M Morales, E Aranda, O Panes, ...
Journal of Thrombosis and Haemostasis 2 (6), 892-898, 2004
1732004
Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: a novel hypothesis for clinically suspected hypercoagulopathy and microvascular …
BM Henry, J Vikse, S Benoit, EJ Favaloro, G Lippi
Clinica Chimica Acta 507, 167-173, 2020
1722020
Mental depression and cardiovascular disease: a multifaceted, bidirectional association
G Lippi, M Montagnana, EJ Favaloro, M Franchini
Semin Thromb Hemost 35 (3), 325-336, 2009
1552009
Utility of the PFA‐100® for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations
EJ Favaloro
Haemophilia 7 (2), 170-179, 2001
1472001
Pre-analytical variables in coagulation testing associated with diagnostic errors in hemostasis
EJ Favaloro, DM Funk, G Lippi
Laboratory Medicine 43 (2), 1-10, 2012
1462012
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20